Featured Research

from universities, journals, and other organizations

Varying Combinations Of Antiviral Drugs May Effectively Treat Chronic Hepatitis Virus Infection In Woodchucks

Date:
October 20, 2008
Source:
American Society for Microbiology
Summary:
Oral administration of various combined and independent antiviral drug therapies may effectively treat chronic hepatitis B virus (HBV) infection in woodchucks, a well-characterized mammalian model for research with human implications, and provide an alternative strategy for managing drug resistance.

Oral administration of various combined and independent antiviral drug therapies may effectively treat chronic hepatitis B virus (HBV) infection in woodchucks, a well-characterized mammalian model for research with human implications, and provide an alternative strategy for managing drug resistance.

Related Articles


The researchers from Cornell University, Ithaca, New York; Gilead Sciences, Durham, North Carolina; and Georgetown University Medical Center, Washington, DC report their findings in the October 2008 issue of the journal Antimicrobial Agents and Chemotherapy.

Chronic infection with HBV is responsible for 1.2 million annual deaths worldwide. Statistics also show that 2 billion people currently or previously suffered from infection while 350 million people are chronic carriers of HBV and are at risk of developing chronic hepatitis, hepatic cirrhosis, and hepatocellular carcinoma. Preventative vaccines are currently offered, however, side effects and drug resistance are limiting the efficacy of available treatment therapies.

In the study researchers evaluated the antiviral effects of orally administered adefovir dipivoxil (ADV) or tenofovir disoproxil fumarate (TDF) alone or in combination with lamivudine (3TC) or emtricitabine (FTC) in woodchucks with chronic hepatitis virus infection. Initial results showed once daily treatment for 48 weeks with ADV plus 3TC or TDF plus FTC greatly reduced viral levels from those pretreatment. Additional treatment with TDF plus 3TC, ADV alone, ADV plus FTC, TDF alone, 3TC alone, and FTC alone showed pronounced declines in viral levels in all groups. Following drug withdrawal most woodchucks displayed renewed hepatitis virus replication, but some did experience sustained effects. Lastly, no toxicity was observed following administration of any of the drugs or drug combinations.

"In conclusion, the oral administration of 3TC, FTC, ADV, and TDF alone and in combination was safe and effective in the woodchuck model of HBV infection," say the researchers.


Story Source:

The above story is based on materials provided by American Society for Microbiology. Note: Materials may be edited for content and length.


Journal Reference:

  1. S. Menne, S.D. Bulter, A.L. George, I.A. Tochkov, Y. Zhu, S. Xiong, J.L. Gerin, P.J. Cote, B.C. Tennant. Antiviral Effects of Lamivudine, Emtricitabine, Adefovir Dipivoxil, and Tenofovir Disoproxil Fumarate Administered Orally Alone and in Combination to Woodchucks with Chronic Woodchuck Hepatitis Virus Infection. Antimicrobial Agents and Chemotherapy, 2008; 52 (10): 3617 DOI: 10.1128/AAC.00654-08

Cite This Page:

American Society for Microbiology. "Varying Combinations Of Antiviral Drugs May Effectively Treat Chronic Hepatitis Virus Infection In Woodchucks." ScienceDaily. ScienceDaily, 20 October 2008. <www.sciencedaily.com/releases/2008/10/081016133509.htm>.
American Society for Microbiology. (2008, October 20). Varying Combinations Of Antiviral Drugs May Effectively Treat Chronic Hepatitis Virus Infection In Woodchucks. ScienceDaily. Retrieved October 30, 2014 from www.sciencedaily.com/releases/2008/10/081016133509.htm
American Society for Microbiology. "Varying Combinations Of Antiviral Drugs May Effectively Treat Chronic Hepatitis Virus Infection In Woodchucks." ScienceDaily. www.sciencedaily.com/releases/2008/10/081016133509.htm (accessed October 30, 2014).

Share This



More Health & Medicine News

Thursday, October 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Fauci Says Ebola Risk in US "essentially Zero"

Fauci Says Ebola Risk in US "essentially Zero"

AP (Oct. 30, 2014) NIAID Director Anthony Fauci said the risk of Ebola becoming an epidemic in the U.S. is essentially zero Thursday at the Washington Ideas Forum. He also said an Ebola vaccine will be tested in West Africa in the next few months. (Oct. 30) Video provided by AP
Powered by NewsLook.com
Nurse Defies Ebola Quarantine With Bike Ride

Nurse Defies Ebola Quarantine With Bike Ride

AP (Oct. 30, 2014) A nurse who vowed to defy Maine's voluntary quarantine for health care workers who treated Ebola patients followed through on her promise Thursday, leaving her home for an hour-long bike ride. (Oct. 30) Video provided by AP
Powered by NewsLook.com
Microsoft Launches Fitness Band After Accidental Reveal

Microsoft Launches Fitness Band After Accidental Reveal

Newsy (Oct. 30, 2014) Microsoft accidentally revealed its upcoming fitness band on Wednesday, so the company went ahead and announced it. Video provided by Newsy
Powered by NewsLook.com
Bracing to Meet a Killer: Aid Workers Prep for Ebola in Geneva

Bracing to Meet a Killer: Aid Workers Prep for Ebola in Geneva

AFP (Oct. 30, 2014) At the International Federation of Red Cross and Red Crescent Societies, around 30 doctors, nurses, lab technicians and water and sanitation workers are gathered for a crash-course in how to safely deal Ebola. Duration: 01:31 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins